KEN CHOW,LIMING WANG,MICHAEL E. GARST,MOHAMMED I. DIBAS,SANTOSH C. SINHA
申请号：
BR112014001938
公开号：
BR112014001938A2
申请日:
2012.07.20
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract of the disclosure the present invention relates to novel n- (imidazolidin-2-ylidene) quinoline derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. ************************************************** ********** Translation of the Summary Patent Summary: "N- (Imidazolidin-2-ylidene) quinoline derivatives as modulators of alpha 2 adrenergic receptors". The present invention relates to novel n- (imidazolidin-2-ylidene) quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as pharmaceuticals.abstract of the disclosure the present invention relates to novel n-(imidazolidin-2-ylidene)quinoline derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. ************************************************************ tradução do resumo resumo patente de invenção: "derivados de n-(imidazolidin-2-ilideno) quinolina como moduladores dos receptores alfa 2 adrenérgicos". a presente invenção refere-se aos novos derivados de n-(imidazolidin-2-ilideno)quinolina, processos para a sua preparação, composições farmacêuticas contendo-os e ao seu uso como produtos farmacêuticos.
